Modified arteriosclerosis score predicts the outcomes of diabetic kidney disease

BMC Nephrology

Table 3 Correlations between clinical features and outcome (endpoint:ESRD or death)

Characteristics	Univariate Models HR (95% CI)	P Value	Clinical Model HR (95% CI)	P Value
Age	0.99(0.97–1.02)	0.79
Female sex	1.24(0.74–2.07)	0.41
Smoke	0.88(0.50–1.56)	0.66
Diabetic retinopathy	1.12(0.66–1.91)	0.67
Diabetes duration	0.98(0.94–1.03)	0.41
BMI	1.00(0.93–1.07)	0.99
Systolic BP	1.02(1.01–1.03)	0.00
HbA1c	0.87(0.73–1.02)	0.08
Total Cholesterol	1.17(1.05–1.31)	0.00
Alb	0.94(0.90–0.97)	0.00	0.95(0.90–0.99)	0.01
Urine protein	1.15(1.08–1.21)	0.00	1.08(1.01–1.15)	0.03
Baseline eGFR	0.96(0.95–0.98)	0.00	0.96(0.95–0.98)	0.00

Clinical Model: Clinical variables with significance at P < 0.1 in univariate models (baseline eGFR, proteinuria, albumin, systolic BP, HbA1c, total cholesterol) were included in the multivariable clinical model, and those that remained significant in the multivariable clinical model were baseline eGFR, urine proteinuria and albumin
Abbreviations: Alb albumin, BMI body mass index, CI confidence interval, eGFR estimated glomerular filtration rate, ESRD end-stage renal disease, HbA1c glycosylated haemoglobin

ISSN: 1471-2369